SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Guy. who wrote (1772)9/28/1998 6:32:00 PM
From: R>G>  Read Replies (5) of 4650
 
Guy, I have a few questions, hopefully you can answer them.
These first two questions are from the post 1578 by Brad.
1. Other types of cancers can also be detected using this technology. Can you list what other types of cancer this technology would work on, and is Biomoda currently working on any of these other cancers?

2. PAP smear tests could also be replaced using this technology.
Is Biomoda doing anything with this now, or is this something down the road?

From the July 1, 1998 Press Release
1. BioModa, Inc. after two years of negotiations, has additionally embarked on a new program in cooperation with the Shanghai Center on New Drug Development in The People's Republic of China (PRC). BioModa will work with the Shanghai Center (owned jointly by the city of Shanghai and the Chinese Government) to provide Shanghai and the country of China with an economical turn-key medical package that will accurately diagnose various forms of lung cancer up to six years earlier than any test currently available.
Any updates on the China deal and providing them with a turn-key medical package? I hear that China is one of the hardest markets to penetrate, if they finalize a deal with China, that would be tremendous.

Thanks Guy

R>G>


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News